Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, and David Geffen, Founder of The David Geffen Foundation. It will serve as the cornerstone of MSK’s foundation for the future and will be instrumental in extending the power and potential of cancer care and treatment to people across New York and around the world as MSK continues to advance cutting-edge research and new cancer treatments.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during The American Society of Hematology (ASH) annual meeting, December 9-12 in San Diego, CA.

Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to amNY Metro and PoliticsNY’s Power Players in Healthcare list.

Campaign — inspired by Matthew Heineman’s new documentary, ‘American Symphony,’ featuring Jon Batiste and Suleika Jaouad — aims to bridge the blood stem cell and marrow donor gap and give hope to patients in need.

The SNO Lifetime Achievement Award is given annually to a meritorious individual who has made significant contributions in neuro-oncology over their career in clinical care and/or translational or basic research.

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that it is ranked among one of the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement today regarding financial results for the nine months ended September 30, 2023.